Muhammad Hameed Khan | Epidemiology | Editorial Board Member

Published on by Global Academic Awards

Mr. Muhammad Hameed Khan | Epidimiology | Editorial Board Member

Quaid-i-Azam University | Pakistan

Mr. Muhammad Hameed Khan is an emerging researcher in medical entomology, parasitology, and infectious disease ecology, with strong expertise in molecular diagnostics, epidemiology, and vector-borne disease surveillance. His research integrates molecular tools, biodiversity assessment, and ecological mapping to investigate malaria dynamics, hard-tick infestations, measles epidemiology, tuberculosis prevalence, and the bioactivity of plant-based nanoparticles. He has contributed to impactful studies on queen bee rearing, silver nanoparticle synthesis, and emerging public health threats, demonstrating versatility across entomology, biotechnology, and disease prevention. His technical strengths span PCR, DNA extraction, ArcGIS mapping, nanoparticle preparation, microscopy, and bioinformatics, supported by excellent analytical, leadership, and independent research capabilities. With multiple publications, conference participations, and organizational roles in scientific events, he is committed to advancing vector control strategies, molecular parasitology, and integrated pest management, making him a strong candidate for competitive research awards and future academic excellence.

Profile: Google Scholar

Featured Publications

1. Khan, M. S., Butt, N., Khan, M. H., Shoaib, M., & Javed, M. (2021). Impact of COVID-19 on the hospitality industry: A review of current findings. Journal of Hospitality and Tourism Management, 46, 205–215.

2. Rehman, N. U., Anjum, S. I., Qureshi, N. A., Khan, M. H., Albasher, G., Kaleem, M., … (2024). The effect of larval age, and wet and dry grafting, on the rearing of queen bees using the Doolittle grafting method. Entomological Research, 54(1), e12700.

3. Siraj, N. (2025). Morphomolecular identification and spatiotemporal distribution of hard ticks infesting cattle: A livestock and public health concern in selected localities of District Swat. The Research of Medical Science Review, 3(5), 33–52.
(If M. H. Khan is a co-author, it may be added accordingly.)

4. Muhammad, M. J. U., Khan, M. H., Siraj, N., Saeed, M. A., Shah, M., … (2024). Green synthesis, characterization, optimization and anti-leishmanial investigation of silver nanoparticles from Citrus sinensis L. fruit peels. Journal of Population Therapeutics & Clinical Pharmacology, 31(10), 382–392.

5. Khan, M. S. M. H., Siraj, N., Khan, A. G., & Ali, S. (2024). Epidemiological patterns, risk factors, and preventive strategies associated with measles infection in children of Tehsil Matta, District Swat, Pakistan. Journal of Population Therapeutics & Clinical Pharmacology, 31.

Barsha Gadapani Pathak | Public Health | Women Researcher Award

Published on by Global Academic Awards

Dr. Barsha Gadapani Pathak | Public Health | Women Researcher Award

Dr. Barsha Gadapani Pathak, University of Bergen and Society for Applied Studies, India

Dr. Barsha Gadapani Pathak is an Indian physician-scientist specializing in public health and implementation science, with a focus on maternal and child health. She is currently pursuing her Ph.D. at the University of Bergen, Norway, and serves as a Scientist at the Society for Applied Studies, New Delhi. With extensive experience in research, policy engagement, and program implementation, she has led and contributed to multiple WHO- and ICMR-funded projects. Her work spans childhood pneumonia, stillbirth prevention, anemia reduction, and kangaroo mother care. She is also a Lancet Citizens’ Commission Fellow and an invited expert for national and international public health forums. 🌍📊👩‍⚕️

Publication Profile

Google Scholar

🎓 Education

Dr. Pathak is currently pursuing a Ph.D. in Public Health with a specialization in Implementation Science and Maternal-Child Health at the University of Bergen, Norway. She holds a Diploma in Community Mental Health from Rajendra Institute of Medical Sciences, Ranchi (2021), and an MD in Community Medicine from Seth GS Medical College & KEM Hospital, Mumbai (2019), where she ranked 3rd in the university. She earned her MBBS from BVP, Pune University in 2013. Her educational background integrates clinical knowledge with public health expertise, providing a strong foundation for her implementation research in health system strengthening. 🎓📚🩺

💼 Experience

Dr. Pathak currently serves as a Scientist at the Society for Applied Studies, New Delhi, since September 2024. Previously, she was a Research Scientist and Young Investigator with PRERNA from 2020 to 2024. She also worked as an Assistant Professor in Community Medicine at KEM Hospital, Mumbai, and as a Medical Officer with the National Health Mission, Assam. With over a decade of cross-disciplinary experience in academia, clinical settings, and global health research, she has contributed extensively to national health programs and WHO guideline development efforts, bridging field implementation with evidence-based policy making. 🧪🏥🌐

🏅 Awards and Honors

Dr. Pathak has received numerous accolades, including the Best Resident Award from the Municipal Corporation of Greater Mumbai (2019) and the Parimala Subramaniyan Award for excellence in Community Medicine (2018). She ranked 3rd in MD Community Medicine at the Maharashtra University of Health Sciences and earned a Certificate of Appreciation at an International Public Health Conference (2020). She has secured multiple prestigious grants from WHO, ICMR, and DJST, and has served as a speaker, expert panelist, and resource person in national and global forums, highlighting her dedication and leadership in advancing public health. 🏆🎖️📜

🔬 Research Focus

Dr. Pathak’s research focuses on implementation science in maternal and child health, particularly improving healthcare delivery for childhood pneumonia, stillbirth prevention, neonatal care (iKMC), and anemia control. She leads and collaborates on WHO- and ICMR-funded projects aimed at translating evidence into scalable health system interventions. Her work combines mixed-methods research with health systems strengthening to reduce mortality and improve care coverage. Additionally, she has contributed to national guidelines and global evidence syntheses on childhood pneumonia and low-birth-weight care. Her studies are impactful, policy-relevant, and grounded in community-based participatory approaches. 👶📈📑

Publication Top Notes

  • Effects of kangaroo mother care on maternal and paternal health: systematic review and meta-analysis – BG Pathak, B Sinha, N Sharma, S Mazumder, N Bhandari 🍼👶 – Cited by 40 – 2023

  • Obesity prevalence and determinants among young adults, with special focus on normal-weight obesity; a cross-sectional study in Mumbai – RS Hadaye, RM Manapurath, BP Gadapani 🍔⚖️ – Cited by 33 – 2020

  • Body composition of infants born with intrauterine growth restriction: a systematic review and meta-analysis – R Manapurath, B Gadapani, L Pereira-da-Silva 🍼📉 – Cited by 27 – 2022

  • Nutritional status of the student nurses of a tertiary health-care center–a mixed-method study – R Hadaye, B Pathak, S Lavangare 🥗💉 – Cited by 18 – 2019

  • Enteral low-dose vitamin A supplementation in preterm or low birth weight infants to prevent morbidity and mortality: a systematic review and meta-analysis – RM Manapurath, M Kumar, BG Pathak, R Chowdhury, B Sinha, … 💊🍼 – Cited by 14 – 2022

  • Mixed-method analysis of community health camps: A novel approach beckoning – A Bhondve, B Pathak, RM Manapurath 🏥👥 – Cited by 14 – 2019

  • Normal weight obesity: role of apoB and insulin sensitivity in predicting future cardiovascular risk – RM Manapurath, R Hadaye, B Gadapani 💔💉 – Cited by 8 – 2022

  • Awareness and acceptance of H1N1 vaccination among physicians: Experience of 2017 vaccination campaign – RS Hadaye, RM Manapurath, BP Gadapani 💉🦠 – Cited by 6 – 2019

  • Combating the pandemic of COVID-19 in India: Health care worker perspective – RMM Barsha Gadapani 🦠🏥 – Cited by 5 – 2020

  • Noncompliance of the postexposure prophylactic vaccination following animal bites reporting to a rural primary health center – RMM Barsha Gadapani, Rahini S 🐕💉 – Cited by 5 – 2019

  • Diet and lifestyle risk factors associated with young adult hypertensives in India–Analysis of National Family Health Survey IV – RM Manapurath, RM Anto, B Pathak, S Malhotra, P Khanna, S Goel 🥦🍔 – Cited by 4 – 2022

  • Analyzing the challenges and demotivating factors faced by accredited social health activist workers in tribal India in implementing their roles – RMM Swati Deshpande, Barsha Gadapani P 🏞️💪 – Cited by 4 – 2019

  • Tobacco smoking and blood pressure: How are they related among the Indians?–A secondary analysis of National Family Health Survey (NFHS)-4 data – BG Pathak, S Rahini, RM Manapurath, BN Sharath, R Gupta, S Goel 🚬💉 – Cited by 3 – 2022

  • Utilizing “Positive deviance inquiry” to explore factors influencing child health: A qualitative study – R Sabale, BG Pathak, RM Manapurath 🧒🩺 – Cited by 3 – 2021

  • Catalyzing healthcare accessibility through cashless payment gateways in India: a digital revolution – BG Pathak, G Mathew, V Chandru, MS Kamath 💳🏥 – Cited by 2 – 2024

Kidanu Hurisa Chachu | Public Health | Best Researcher Award

Published on by Global Academic Awards

Dr. Kidanu Hurisa Chachu | Public Health | Best Researcher Award

Dr. Kidanu Hurisa Chachu,Network of Networks of HIV Positives in Ethiopia (NEP+), Ethiopia

Dr. Kidanu Hurisa Chachu is a seasoned Senior Public Health Specialist with over 16 years of extensive experience in the field. With a PhD in Public Health and advanced degrees in the same discipline, he has demonstrated leadership in managing national programs in HIV, TB, immunization, and environmental health. Currently serving as the Program Director at NEP+, he oversees strategic implementation across 300+ health facilities, coordinating community-based HIV care and psychosocial support. Previously, he served as a Technical Officer at UNDP, where he strengthened health and environment programs at the national level. His core strengths include project coordination, M&E, stakeholder engagement, data management, and advocacy. Dr. Kidanu is multilingual, fluent in English, Afan Oromo, and Amharic. His career is marked by data-driven decision-making, community impact, and successful partnerships with international donors, such as the Global Fund, UNAIDS, and PEPFAR.

Publication Profile

Google Scholar

🎓 Education

Dr. Kidanu holds a Doctor of Philosophy in Public Health from the University of South Africa (UNISA), where he is finalizing his doctoral research. His academic journey began with a Bachelor of Science in Public Health from Haramaya University in Ethiopia, completed in 2008. Driven by a passion for community health, he further pursued his Master’s degree in General Public Health from Wollega University, graduating in 2016. Throughout his academic path, Dr. Kidanu has focused on strengthening health systems, improving disease surveillance, and addressing public health challenges in resource-limited settings. His studies emphasize a strong foundation in research, statistical analysis, and results-based management, all of which are evident in his professional approach. His academic background has been essential to his leadership roles and to his ability to drive impactful, evidence-based public health interventions.

💼 Experience

Dr. Kidanu currently leads NEP+ as Program Director, overseeing HIV response strategies across Ethiopia. He manages over 600 adherence supporters and leads national initiatives like Community-Led Monitoring (CLM), economic empowerment, and mother support groups. Prior to NEP+, he served as Technical Officer at UNDP (2021–2024), providing strategic and technical guidance on health and environment programs. There, he collaborated with the Ministry of Health and Environmental Protection Authority to improve project outcomes, mobilize resources, and manage donor-funded initiatives. His earlier experience spans clinical practice, research, and M&E roles that focused on HIV, TB, immunization, and environmental health. Dr. Kidanu’s hands-on experience in fieldwork, stakeholder engagement, and donor coordination reflects his dedication to delivering sustainable public health outcomes and system strengthening across Ethiopia.

🏅 Awards and Honors

While specific awards are not explicitly listed, Dr. Kidanu’s career achievements reflect recognition at both national and international levels. At NEP+, he led the successful scale-up of key initiatives including Community-Led Monitoring and economic empowerment programs for PLHIV, achievements often recognized by partner institutions and donors. His leadership has enhanced Ethiopia’s HIV treatment adherence and digital M&E systems. At UNDP, his work contributed to policy development and was praised for aligning with SDG targets and donor expectations, particularly in collaboration with the EU and MoH. His consistent success in grant writing, program reporting, and stakeholder coordination underscores a highly commendable career. His track record suggests recognition through internal promotions, project expansions, and trusted leadership in donor-funded programs, affirming his status as a key figure in Ethiopia’s public health sector.

🔬 Research Focus

Dr. Kidanu’s research focus centers on health systems strengthening, monitoring and evaluation (M&E), and community-led HIV interventions. His doctoral work at UNISA contributes to the evidence base for improving adherence support, stigma reduction, and access to treatment in Ethiopia. His academic and field research explore the intersections of public health, environmental factors, and chronic disease management. He emphasizes participatory approaches, particularly Community-Led Monitoring (CLM), to generate real-time data and inform policy. Additionally, he’s contributed to studies involving maternal and child health, digital health systems, and the socio-economic empowerment of PLHIV. His evidence-driven strategies are reflected in national programs that integrate research findings into scalable interventions. His work contributes to global dialogues on sustainable HIV responses and health equity in low-resource settings.

Publication Top Notes

📘 Prevalence and Factors Associated with Current Cigarette Smoking among Ethiopian University Students: A Systematic Review and Meta‐Analysis – Journal of Addiction – Cited by: 21 – Year: 2020 🔍🚬📊
📘 Strategies for strengthening same-day ART initiation, tracing people living with HIV lost to follow-up and viral load monitoring mechanisms in Ethiopia – HIV Medicine – Cited by: 0 – Year: 2025 🧬📈👥
📘 Viral suppression among patients in HIV/AIDS care at healthcare facilities in Ethiopia: Same-day antiretroviral initiation – PLOS ONE – Cited by: 0 – Year: 2025 💊📉🏥
📘 Retention of patients in HIV/AIDS care at the healthcare facility level in Ethiopia: Same-day antiretroviral initiation status – Unspecified Journal – Cited by: 0 – Year: 2024 🏥🔄🧪
📘 Same-day antiretroviral therapy initiation and its association with viral suppression and retention in HIV care in Ethiopia – University of South Africa (Thesis) – Cited by: 0 – Year: 2024 🎓📚📉
📘 Strategies for strengthening same-day ART initiation, tracing people living with HIV lost to follow-up and viral load monitoring mechanisms in Ethiopia – HIV Medicine (duplicate) – Cited by: 0 – Year: 2025 🔁📊🧬

Sylvia Kusemererwa | Public Health | Best Researcher Award

Published on by Global Academic Awards

Dr. Sylvia Kusemererwa | Public Health | Best Researcher Award

Dr. Sylvia Kusemererwa, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Uganda

Dr. Sylvia Kusemererwa is a distinguished Scientist A, Project Leader, and Principal Investigator at MRC/UVRI & LSHTM Uganda Research Unit. She holds an MBChB and MPH from Makerere University and has extensive experience in clinical research, epidemiology, and infectious disease management. Dr. Kusemererwa has led multiple clinical trials on HIV prevention, malaria vaccines, and COVID-19 research. She actively contributes to national health policies, serving as Chair of the Masaka Regional Referral Hospital Research Ethics Committee. Her work has significantly impacted public health in Uganda and beyond. 📍

Publication Profile

Orcid

🎓 Education

Dr. Kusemererwa earned her MBChB (2001) and MPH (2010) from Makerere University, equipping her with expertise in public health and clinical research. She pursued specialized training in project management (PRINCE2), global health leadership (Afya Bora Fellowship), and research ethics. She has completed advanced courses in statistics, epidemiology, and scientific manuscript writing. Her certifications include GCP from LSHTM and Citiprogram HSP. Her continuous learning reflects her dedication to high-quality clinical trials and ethical research governance. 📚

👩‍⚕️ Experience

Dr. Kusemererwa has held key positions, including Scientist A at MRC Uganda, Clinical Coordinator at TASO Mbale, and Medical Officer at Kampala Medical Chambers. She has been a Principal Investigator and Study Coordinator for numerous trials on HIV vaccines, COVID-19, and malaria. Her leadership in clinical research spans over two decades, significantly advancing Uganda’s infectious disease research landscape. She also mentors researchers and chairs ethics committees, ensuring adherence to international research standards. 🏥

🏆 Awards & Honors

Dr. Kusemererwa has been recognized for her contributions to public health and research ethics. She is Chair of the Masaka Regional Referral Hospital Research Ethics Committee and a mentor in the MRC-CTU Mentorship Scheme. She has received fellowships in global health leadership and numerous accolades for her role in advancing vaccine research and ethical clinical trials in Uganda. Her commitment to scientific excellence has established her as a leader in biomedical research. 🌍

🔬 Research Focus

Dr. Kusemererwa specializes in clinical trials for infectious diseases, focusing on HIV prevention, malaria vaccines, and emerging infections like COVID-19. She has led Phase 2 and 3 trials on HIV PrEP, vaccine efficacy, and maternal immunization. Her research emphasizes public health impact, implementation science, and ethical considerations in clinical studies. She collaborates globally to optimize vaccine deployment and improve healthcare interventions in sub-Saharan Africa. 🧪

Publication Top Notes

  • “Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda” (2021)

    pmc.ncbi.nlm.nih.gov

  • “Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda” (2022)

    journals.plos.org

  • “Associations between intravaginal practices and incidence of sexually transmitted infections and bacterial vaginosis among women enrolled in the dapivirine vaginal ring trial (The Ring Study) in southwestern Uganda: a retrospective secondary analysis” (2024)

    bmjopen.bmj.com

  • “Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, Uganda” (2023)

  • “Contraceptive Preference Among Women at Risk of HIV Acquisition in Southwestern Uganda” (2018)

 

 

Pedro de Marchi | Epidemiology | Academic Engagement Excellence Award

Published on by Global Academic Awards

Dr. Pedro de Marchi | Epidemiology | Academic Engagement Excellence Award

Dr. Pedro de Marchi, ONCOCLINICAS, Brazil

Dr. Pedro de Marchi is a leading medical oncologist specializing in head and neck cancer at Oncoclínicas, Brazil. He serves as the National Leader and Medical Coordinator, alongside being a Professor of Medicine at Universidade Estadual do Rio de Janeiro. Dr. Marchi completed his MD at Universidade Federal de Santa Maria and furthered his training in internal medicine and oncology. His research focuses on the efficacy of immune checkpoint inhibitors and head and neck squamous cell carcinoma. Dr. Marchi has led several significant studies and has been involved in numerous conferences to advance cancer treatment. 🎗️👨‍⚕️📚

Publication Profile

Google Scholar

Education

Dr. Pedro de Marchi earned his MD from Universidade Federal de Santa Maria (UFSM) in 2008. He completed a residency in Internal Medicine at the Universidade Federal do Rio Grande do Sul and a Clinical Fellowship in Medical Oncology at Hospital São Lucas (PUC-RS). He further enriched his expertise through an observership at The University of Texas MD Anderson Cancer Center. Dr. Marchi holds a Master’s in Oncology from Fundação Pio XII, focusing on chemotherapy toxicity in head and neck cancer, and a PhD in Oncology, studying immune checkpoint inhibitors and biomarkers in lung cancer. 🎓💉📖

 

Experience and Service

Dr. Pedro de Marchi has an extensive career in oncology, serving as a resident at Universidade Federal do Rio Grande do Sul (2009-2011) and a Medical Oncology Fellow at Hospital São Lucas (2011-2014). He was the Head of Thoracic and Head & Neck Oncology at Barretos Cancer Hospital (2016-2020) and is currently a National Leader in Head & Neck Cancer at Oncoclínicas. In addition, he coordinates multiple fellowship programs and serves as a Professor of Medicine at Universidade Estadual do Rio de Janeiro. His leadership roles reflect his commitment to advancing oncology care and research. 🩺🌟📚

 

Honors and Awards

Dr. Pedro de Marchi was recognized with the AMRIGS Medical Qualification by the Medical Association of Rio Grande do Sul in Porto Alegre, Brazil, in 2008. This prestigious honor highlights his dedication to the medical field and his commitment to achieving excellence in healthcare. The award underscores his professional qualifications and serves as a testament to his skills as a medical practitioner. Dr. de Marchi’s achievements reflect his continuous pursuit of knowledge and his contribution to advancing medical practice in Brazil. 🏆🎓🌟

 

Research Contributions

Dr. Pedro de Marchi has made significant contributions to cancer research through various grants and contracts. As the Principal Investigator, he led studies on head and neck squamous cell carcinoma epidemiology and COVID-19 mortality determinants among cancer patients, securing substantial funding from notable organizations like MSD, AMGEN, and AstraZeneca. His research includes pivotal Phase III trials assessing innovative treatments for squamous cell carcinoma. These efforts not only advance medical knowledge but also aim to improve patient outcomes in Brazil. Dr. de Marchi’s work is essential in addressing critical health challenges in oncology. 📊🔬🎗️

 

Teaching

Dr. Pedro de Marchi plays a vital role in medical education and mentorship. He serves as a Clinical Research Mentor in the Oncoclinicas Mentorship Programme since 2024, fostering the next generation of oncologists. As a Professor at Universidade Estadual do Rio de Janeiro (UERJ), he instructs rotating medical students, enhancing their clinical skills. Additionally, Dr. de Marchi supervises postdoctoral research fellows in Internal Medicine and Thoracic and Head & Neck Medical Oncology, guiding them in their academic and clinical pursuits. His commitment to education ensures that future physicians are well-equipped for the challenges of oncology. 📚👨‍⚕️🎓

 

Conclusion

Dr. Pedro de Marchi exemplifies the qualities sought after for the Research for Academic Engagement Excellence Award. His leadership in cancer research, dedication to education, and significant contributions to the field make him a suitable candidate for this prestigious recognition.

Publication Top Notes

  • Pembrolizumab versus chemotherapy for untreated PD-L1-expressing NSCLC (KEYNOTE-042) 🌟 — Cited by: 3065, Year: 2019
  • Durvalumab plus platinum–etoposide for extensive-stage SCLC (CASPIAN) 🎯 — Cited by: 1679, Year: 2019
  • First-line nivolumab plus ipilimumab and chemotherapy in NSCLC (CheckMate 9LA) 🚀 — Cited by: 1086, Year: 2021
  • Durvalumab with/without tremelimumab for extensive-stage SCLC (CASPIAN) ⚖️ — Cited by: 487, Year: 2021
  • CheckMate 9LA 2-year update: nivolumab plus ipilimumab and chemotherapy vs. chemotherapy alone 🕒 — Cited by: 172, Year: 2021
  • Lung cancer in Brazil 🇧🇷 — Cited by: 142, Year: 2018
  • PD-L1 expression in NSCLC: TPS vs. CPS 🧬 — Cited by: 77, Year: 2021
  • Câncer de pulmão no Brasil 📈 — Cited by: 70, Year: 2018
  • MiR-21 as a prognostic biomarker in head and neck SCC 📊 — Cited by: 69, Year: 2017
  • Determinants of COVID-19 mortality in cancer patients in Brazil 🦠 — Cited by: 50, Year: 2021